OPTIC, ATROPHY, HEREDITARY, LEBER
Clinical trials for OPTIC, ATROPHY, HEREDITARY, LEBER explained in plain language.
Never miss a new study
Get alerted when new OPTIC, ATROPHY, HEREDITARY, LEBER trials appear
Sign up with your email to follow new studies for OPTIC, ATROPHY, HEREDITARY, LEBER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy offers hope for rare blindness condition
Disease control CompletedThis study tested a gene therapy called GS010 for people with Leber Hereditary Optic Neuropathy (LHON), a rare inherited eye disease that leads to vision loss. The trial included 37 participants who had vision loss for 6 to 12 months. They received a single injection of GS010 or …
Matched conditions: OPTIC, ATROPHY, HEREDITARY, LEBER
Phase: PHASE3 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Gene therapy shows promise for rare eye disease
Disease control CompletedThis study tested a one-time gene therapy injection (GS010) in 39 people with Leber Hereditary Optic Neuropathy (LHON), a genetic condition that causes rapid vision loss. Participants had vision loss for 6 months or less. The goal was to see if the treatment could improve eyesigh…
Matched conditions: OPTIC, ATROPHY, HEREDITARY, LEBER
Phase: PHASE3 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated May 04, 2026 16:30 UTC